News

Filter by year:

Filter by tags:

5/28/2020

Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project

Renowned program led by James M. Wilson, MD, PhD, a leading expert in the technology platform used in the experimental vaccine, to conduct preclinical studies in joint research and development project with Massachusetts Eye and Ear and Massachusetts General Hospital.

5/28/2020

Big gene therapy names line up behind experimental Covid-19 vaccine

An early stage vaccine against Covid-19 based on the same basic technology used in gene therapy is gaining some support from some of that field’s biggest names.

5/28/2020

Novartis Inks Deal to Make Experimental Coronavirus Vaccine

Swiss drugmaker will make gene-based Covid-19 vaccine being developed at Massachusetts Eye and Ear, Massachusetts General Hospital and University of Pennsylvania

5/12/2020

Passage Bio Announces Presentation of Data from Animal Models of Krabbe Disease at the American Society of Gene & Cell Therapy (ASGCT) 23rd Annual Meeting

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced the presentation of preclinical data for its Krabbe disease program. This data was presented today in a virtual oral presentation at the American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting by Juliette Hordeaux, D.V.M., Ph.D., senior director of translational research at the University of Pennsylvania’s Gene Therapy Program.

5/08/2020

Million Dollar Bike Ride

7TH ANNUAL MILLION DOLLAR BIKE RIDE: June 13, 2020 NOW A VIRTUAL EVENT!

5/07/2020

Passage Bio Announces Expansion of Gene Therapy Collaboration with University of Pennsylvania

We are thrilled that our collaboration with Passage Bio is expanding!